Eur J Anaesthesiol 29: 398400, 2012 [DOI] [PubMed] [Google Scholar] 34.Zand L, Muriithi A, Nelsen E, Franco PM, Greene EL, Qian Q, El-Zoghby ZM: Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation
Innovation Directions Rather than pursuing oral convenience, leading companies focus on injectable innovation: Extended-release formulations reducing injection frequency (monthly, quarterly) Multi-target mechanisms enhancing efficacy beyond single GLP-1 activation Combination therapies addressing multiple obesity pathways simultaneously Improved delivery devices enhancing patient experience with injections Amgens monthly MariTide exemplifies this approach, achieving 20% weight loss with just 12 annual injections versus 52 for weekly alternatives
Curr Neuropharmacol (2017) 15(6):92635
Studies have indicated that GLP-1R is involved in regulating cell proliferation and migration, neuronal activity, and inflammation through its downstream PI3K/Akt pathway [23, 42, 63]